159 related articles for article (PubMed ID: 14676041)
1. Treatments of Parkinson disease: circa 2003.
Shults CW
Arch Neurol; 2003 Dec; 60(12):1680-4. PubMed ID: 14676041
[TBL] [Abstract][Full Text] [Related]
2. Overview of Parkinson's disease.
Lew M
Pharmacotherapy; 2007 Dec; 27(12 Pt 2):155S-160S. PubMed ID: 18041935
[TBL] [Abstract][Full Text] [Related]
3. Importance of treatment of depression in assuring the most efficacious management of Parkinson's disease.
Kaiser HE; Bodey B; Bodey B
In Vivo; 2000; 14(3):457-62. PubMed ID: 10904882
[TBL] [Abstract][Full Text] [Related]
4. Parkinson's disease.
Constantino AE; Honig LS
Sci Aging Knowledge Environ; 2001 Nov; 2001(7):dn4. PubMed ID: 14602969
[TBL] [Abstract][Full Text] [Related]
5. [Concept and diagnostic criteria of Parkinson's disease and parkinsonism].
Mizuno Y
Nihon Rinsho; 1997 Jan; 55(1):16-20. PubMed ID: 9014417
[TBL] [Abstract][Full Text] [Related]
6. Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients.
Prescott IA; Dostrovsky JO; Moro E; Hodaie M; Lozano AM; Hutchison WD
Brain; 2009 Feb; 132(Pt 2):309-18. PubMed ID: 19050033
[TBL] [Abstract][Full Text] [Related]
7. New therapeutic approaches to Parkinson's disease including neural transplants.
Kuan WL; Barker RA
Neurorehabil Neural Repair; 2005 Sep; 19(3):155-81. PubMed ID: 16093408
[TBL] [Abstract][Full Text] [Related]
8. Parkinson disease and exercise.
Earhart GM; Falvo MJ
Compr Physiol; 2013 Apr; 3(2):833-48. PubMed ID: 23720332
[TBL] [Abstract][Full Text] [Related]
9. Molecular pathogenesis of Parkinson disease.
Eriksen JL; Wszolek Z; Petrucelli L
Arch Neurol; 2005 Mar; 62(3):353-7. PubMed ID: 15767499
[TBL] [Abstract][Full Text] [Related]
10. Parkinson's disease: clinical aspects.
Klockgether T
Cell Tissue Res; 2004 Oct; 318(1):115-20. PubMed ID: 15365814
[TBL] [Abstract][Full Text] [Related]
11. Beating a dead horse: dopamine and Parkinson disease.
Ahlskog JE
Neurology; 2007 Oct; 69(17):1701-11. PubMed ID: 17954785
[TBL] [Abstract][Full Text] [Related]
12. Etiology and pathogenesis of Parkinson's disease.
Olanow CW; Tatton WG
Annu Rev Neurosci; 1999; 22():123-44. PubMed ID: 10202534
[TBL] [Abstract][Full Text] [Related]
13. Shedding light into the role of BDNF in the pharmacotherapy of Parkinson's disease.
Fumagalli F; Racagni G; Riva MA
Pharmacogenomics J; 2006; 6(2):95-104. PubMed ID: 16402079
[TBL] [Abstract][Full Text] [Related]
14. Parkinson's disease: from genetics to treatments.
Fan HC; Chen SJ; Harn HJ; Lin SZ
Cell Transplant; 2013; 22(4):639-52. PubMed ID: 23127617
[TBL] [Abstract][Full Text] [Related]
15. Morphological alterations of the synapses in the locus coeruleus in Parkinson's disease.
Baloyannis SJ; Costa V; Baloyannis IS
J Neurol Sci; 2006 Oct; 248(1-2):35-41. PubMed ID: 16753180
[TBL] [Abstract][Full Text] [Related]
16. Postural instability in Parkinson's disease: the adrenergic hypothesis and the locus coeruleus.
Grimbergen YA; Langston JW; Roos RA; Bloem BR
Expert Rev Neurother; 2009 Feb; 9(2):279-90. PubMed ID: 19210201
[TBL] [Abstract][Full Text] [Related]
17. Dopaminergic neurons.
Chinta SJ; Andersen JK
Int J Biochem Cell Biol; 2005 May; 37(5):942-6. PubMed ID: 15743669
[TBL] [Abstract][Full Text] [Related]
18. Optimizing therapeutic effects in patients with comorbidities: drug-resistant tremor, autonomic dysfunction, psychiatric disorders, and cognitive impairment.
Chitnis S
Neurol Clin; 2008 Aug; 26(3 Suppl):S29-44, v-vi. PubMed ID: 18774441
[TBL] [Abstract][Full Text] [Related]
19. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
Novikova L; Garris BL; Garris DR; Lau YS
Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
[TBL] [Abstract][Full Text] [Related]
20. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
